TREE NEWS update: Bepirovirsen, the world’s first functional cure drug for hepatitis B, achieved up to 61% functional cure rate in Chinese patients, according to data from the global Phase III B-Well study presented by Professor Hou Jinlin at the Asian Hepatology Summit in Singapore on September 4. The drug was approved in Japan in August.
Bepirovirsen shows 61% functional cure rate in Chinese HBV patients
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
12m ago
China Logistics Prosperity Index Rises to 50.9% in August
25m ago
Uruguay declares health emergency over H5 bird flu
36m ago
Nepal landslide death toll rises to 1,342, 4,898 missing
44m ago
China’s Gyirong landslide donations top 660M yuan
53m ago
US Military Probes Leak of Advanced Weapons Stockpile Info
1h ago
Canada Faces Data Center Backlash as AI Plans Advance